4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000905718-17-000732
Director sold 32,930 shares at an average $17.60 ($579,545)
From the SEC's structured data for this filing
Trades in this filing
EMSTER KURT VON · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-07-25 | Sale : show line 1 in the form | −9,186 | $17.52 | $160,939 | 2,347,390 | I |
| 2017-07-26 | Sale : show line 2 in the form | −23,744 | $17.63 | $418,607 | 2,323,646 | I |
| Open-market sales · 32,930 sh · avg $17.60 · $579,545 | ||||||
Loading xslF345X03/vonemster_fm4july252017.xml…